Transdermal Drug Delivery Systems Market Drivers, Challenges, Key Regions and Forecast by 2023 | Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG

UPDATE AVAILABLE ON-DEMAND

Global immunoprotein diagnostic testing market generated $17.74 billion in 2017, and is estimated to generate $27.29 billion by 2023, growing at a CAGR of 7.4% from 2017 to 2023. The report provides an extensive analysis of market dynamics, top investment pockets, market size & projections, major segments, and competitive landscape.

Download Sample Copy of this Report @ https://www.alliedmarketresearch.com/request-sample/486

Major determinants of the market

Rise in incidence of chronic and infectious diseases and advancements in technologies have boosted the growth of the global immunoprotein diagnostic testing market. However, stringent regulations hamper the market. On the contrary, potential in the emerging economies and development of condition-specific assays and tests are expected to create opportunities for the market players in the future.

COVID-19 scenario:

Due to lockdown across the globe, there is significant gap in supply and demand. Moreover, the supply chain has been disrupted.

However, the demand for immunoprotein diagnostic testing is increasing as it could be used to diagnose cardiovascular and infectious diseases.

Request for Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/486?reqfor=covid

Among applications, the infectious disease testing segment held nearly one-fourth of the total share in terms of revenue in 2017, owing to rise in incidence of infectious diseases across the world. However, the oncology testing segment is estimated to grow at the fastest CAGR of 7.8% throughout the forecast period, owing to considerable increase in different types of cancer cases throughout the world including colorectal cancer, lung cancer, and others. The research also analyzes allergy testing, autoimmune testing, toxicology testing, endocrine testing, among others.

The oncology testing segment to manifest the highest share

By type, the oncology testing segment is expected to manifest the highest CAGR of 8.0% during the forecast period, due to increasing number of cancer patients worldwide. However, the infectious disease testing segment held the largest share in 2019, contributing to more than one-fifth of the global immunoprotein diagnostic testing market, owing to higher prevalence of infectious diseases such as hepatitis B, hepatitis C, HIV-1, HIV-1/2, and human T-lymphotropic virus types I & II.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/486

North America to dominate, Asia-Pacific to be the fastest growing through 2023

Major market players

Abbott Laboratories
Bio-Rad Laboratories
Abcam PLC
Diasorin
Danaher Corporation
Ortho Clinical Diagnostics
Enzo Life Sciences
Siemens Healthcare
Roche Diagnostics
Thermo Fisher Scientific

North America accounted for 40% of the market share in 2017 and is expected to maintain its dominant position through the forecast period. This is attributed to the presence of leading diagnostic product manufacturers, higher adoption of advanced and efficient diagnostic products, heavy inflow of investment in proteomics research & drug development, and surge in the number of patients with viral infections and cancer in the region. On the other hand, Asia-Pacific is expected to grow at the fastest CAGR of 8.8% from 2017 to 2023, owing to factors such as higher adoption of point-of-care technology, rapidly growing geriatric population, and rise in incidence of chronic diseases in the region. The other regions discussed in the study are Europe, and Latin America, Middle East, and Africa (LAMEA).

Read More @ https://www.alliedmarketresearch.com/press-release/immunoprotein-diagnostic-testing-market.html

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.